Effects of ovulation induction agents on ovarian surface epithelium in rats.
The aim of this study was to examine the effects of ovulation induction agents on the ovarian surface epithelium in rats. Sixty adult females were randomly divided into six groups, each containing 10 rats. In four of these groups ovulation induction was applied with six cycles of clomiphene citrate, human menopausal gonadotrophin (HMG), recombinant FSH (rFSH) or human chorionic gonadotrophin (HCG), respectively, followed by unilateral oophorectomy, and another six cycles of the same treatment. After a total of 12 cycles of ovulation induction, the remaining ovary was taken out and the alterations in ovarian surface epithelium were examined. No malignancies were observed on the ovarian surface epithelium of the rats that were given clomiphene citrate, rFSH or HMG as ovulation induction agents, while identification rates of histopathological parameters constituting epithelial dysplasia were found to be significant (P < 0.05). There was no significant dysplasia in the epithelium of the group which was given HCG only, relative to control groups. The findings suggest that the ovulation induction agents except for HCG bring about dysplasia in the ovarian surface epithelium. It is not clear whether these dysplasias are precursory lesions of ovarian malignancies.
Firat University, Medical School, Department of Obstetrics and Gynecology, Elazig, Turkey.
Zeynep
Z
Ozcan
Husnu
H
Celik
Bilgin
B
Gurates
Hanifi Ibrahim
HI
Ozercan
Fethi
F
Hanay
Mehmet
M
Nalbant
Zeynep
Z
Dogan
D000818:Animals; D006063:Chorionic Gonadotropin / Q000009:adverse effects / Q000494:pharmacology; D002996:Clomiphene / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004848:Epithelium / Q000187:drug effects*; D005260:Female; D005300:Fertility Agents, Female / Q000009:adverse effects / Q000494:pharmacology*; D006801:Humans; D008596:Menotropins / Q000494:pharmacology; D010049:Ovarian Diseases / Q000139:chemically induced; D010053:Ovary / Q000187:drug effects*; D010062:Ovulation Induction / Q000009:adverse effects / Q000379:methods; D011897:Random Allocation; D051381:Rats
D006063:Chorionic Gonadotropin; D005300:Fertility Agents, Female; D002996:Clomiphene; D008596:Menotropins